Access & reimbursement

Europe’s Infection Gap Starts At The Clinic Door

Pembrolizumab Just Lost a Head-to-Head Survival Fight

SMA Treatment Finally Reaches the Muscle

HER2-Mutant Lung Cancer Just Moved Into First Line

Cancer Screening Is Still Designed for the Able-Bodied Patient

MOGAD Is Close to Its First Real Treatment

Menstrual Migraine Was Never Just Regular Migraine

Insurance is not access: Nearly half of insured adults with multiple conditions report delays or denials

Brain Cancer Finally Gets the PET Scan It Has Been Missing
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
